IceCure Medical
ICCM
9 hedge funds and large institutions have $174K invested in IceCure Medical in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
2% more capital invested
Capital invested by funds: $172K → $174K (+$2.82K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$14.5K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$35K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$602 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$542 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
JP Morgan Chase
New York
| $78K | +$14.5K | +241 | New |
|
|
2
Bank of America
Charlotte,
North Carolina
| $45K | -$602 | -10 | -1% |
|
|
BFM
3
Boothbay Fund Management
New York
| $34K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $7K | -$542 | -9 | -7% |
|
|
BCM
5
Bourgeon Capital Management
Darien,
Connecticut
| $5K | – | – | – |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $4K | +$1.32K | +22 | +33% |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
BCWM
8
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $427 | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$35K | -480 | Closed |
|
ICCM Hedge Fund Activity: Q2 2022 in Review
9 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q2 2022, worth a combined $174K — up 1.6% from $172K a quarter earlier.
Fund positioning in ICCM was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $14.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $35K sold.
- 9 institutional investors held IceCure Medical (ICCM) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $174K of IceCure Medical stock for Q2 2022, up 1.6% quarter-over-quarter.
- 1 fund opened new IceCure Medical positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest IceCure Medical buyer in Q2 2022 was JP Morgan Chase, an estimated $14.5K added.
- The largest IceCure Medical seller in Q2 2022 was Citadel Advisors, an estimated $35K sold.
Based on aggregated 13F filings for Q2 2022.